Wang Fusheng

[Expert Profile] Wang Fusheng, Chief Physician, Professor, Doctoral Supervisor, Academician of the Chinese Academy of Sciences, is an authoritative expert in infectious diseases and hepatology in China, working at the Fifth Medical Center of Chinese PLA General Hospital. He has long been dedicated to clinical diagnosis, treatment, and immunological research of chronic difficult liver diseases and parasitic infections, and is an important leading figure in infection immunity and hepatology both domestically and internationally.

[Education & Career] Professor Wang Fusheng graduated from a military medical university, completed systematic clinical training at the Fifth Medical Center of Chinese PLA General Hospital (formerly 302 Hospital), and further studied at famous international medical centers. He has long served as Director of the Infectious Diseases Medical Department at the Fifth Medical Center of Chinese PLA General Hospital and Director of the National Clinical Research Center for Infectious Diseases. He was elected as an Academician of the Chinese Academy of Sciences in 2015, and has held important academic positions including Chair of the Infectious Diseases Branch of the Chinese Medical Association. He is an academic leader in the field of infection and hepatology immunology in China.

[Areas of Expertise] Professor Wang specializes in the diagnosis and treatment of chronic difficult liver diseases such as chronic hepatitis B, liver cirrhosis, and liver failure, as well as standardized diagnosis and treatment of various parasitic infections. He has profound expertise in antiviral therapy, immunotherapy, and functional cure exploration for hepatitis B, comprehensive treatment of liver failure, and stem cell therapy. He excels at managing difficult liver disease cases from an immunological perspective, such as "disease progression despite antiviral therapy" and "immune tolerance," helping numerous patients slow liver cirrhosis progression and avoid liver failure.

[Academic Achievements & Industry Contributions] Professor Wang has led the establishment of an immunological clinical research platform for infectious diseases, systematically elucidating the cellular immune mechanisms of immune tolerance and clearance in chronic hepatitis B, and leading innovative clinical research on stem cell therapy for liver failure, with findings published in top international journals. He has led the development of Chinese hepatitis B prevention and treatment and infectious disease diagnosis and treatment guidelines, actively participated in immunological research and clinical treatment of major infectious disease outbreaks, and has repeatedly served as a core member of national expert panels, making outstanding contributions to the development of infectious diseases and hepatology and the prevention and control of infectious diseases in China.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of infection and liver disease clinical work, Professor Wang has treated tens of thousands of patients with various liver diseases and infectious diseases, leading his team in successfully managing numerous critical liver failure patients. He has received multiple national awards including the National Science and Technology Progress Award, and has been repeatedly recognized as a national outstanding science and technology worker. He has trained a large number of leaders in infection immunity and hepatology, and is a truly deserving authoritative expert in the field of infectious diseases in China, deeply admired by patients and peers alike.

[Honors & Reputation] Professor Wang Fusheng serves as Director of the Infectious Diseases Medical Department at the Fifth Medical Center of Chinese PLA General Hospital and Director of the National Clinical Research Center for Infectious Diseases, among other academic positions. He was elected as an Academician of the Chinese Academy of Sciences in 2015, has presided over national-level major projects including the National Key R&D Program, and is an authoritative expert in the fields of infectious diseases and hepatology in China. He has profound expertise in comprehensive treatment and immunological research of chronic difficult liver diseases and liver failure. He has led innovative clinical research on stem cell therapy for liver failure, systematically elucidating the immune tolerance and clearance mechanisms of chronic hepatitis B, with findings published in top international journals. He has repeatedly served as a core member of national infectious disease prevention and control expert panels, and has trained a large number of leaders in infection and hepatology. He is deeply trusted by patients and respected by peers alike.